NCT01618747View on ClinicalTrials.gov

An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

March 15, 2013

Primary Completion Date

December 24, 2015

Study Completion Date

December 24, 2015

Conditions
Glioblastoma Multiforme
Trial Locations (3)

11217

Taipei

83301

Kaohisung

00014

Taipei

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01618747 - An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse | Biotech Hunter | Biotech Hunter